Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
9.88
-0.46 (-4.45%)
Apr 15, 2026, 4:00 PM EDT - Market closed
Upstream Bio Stock Forecast
Stock Price Forecast
The 3 analysts that cover Upstream Bio stock have a consensus rating of "Buy" and an average price target of $37.67, which forecasts a 281.28% increase in the stock price over the next year. The lowest target is $15 and the highest is $51.
Price Target: $37.67 (+281.28%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Upstream Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 2 | 2 | 2 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy → Hold Downgrades $40 → $15 | Buy → Hold | Downgrades | $40 → $15 | +51.82% | Mar 27, 2026 |
| Mizuho | Mizuho | Buy Initiates $51 | Buy | Initiates | $51 | +416.19% | Dec 18, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $40 | Buy | Initiates | $40 | +304.86% | Nov 18, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $47 | Strong Buy | Initiates | $47 | +375.71% | Oct 14, 2025 |
| JP Morgan | JP Morgan | Buy Initiates $38 | Buy | Initiates | $38 | +284.62% | Nov 5, 2024 |
Financial Forecast
Revenue This Year
1.51M
from 2.85M
Decreased by -47.20%
Revenue Next Year
1.27M
from 1.51M
Decreased by -16.06%
EPS This Year
-3.00
from -2.66
EPS Next Year
-3.24
from -3.00
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.2M | 3.0M | |||
| Avg | 1.5M | 1.3M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 47.2% | 101.4% | |||
| Avg | -47.2% | -16.1% | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -2.45 | -2.17 | |||
| Avg | -3.00 | -3.24 | |||
| Low | -3.60 | -3.94 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.